Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|February 1, 2005
- Volume 0 0
Conference to Discuss Urologic Advances
Advertisement
The Society of Urologic Nurses and Associates (SUNA) will hold its Annual Symposium: Disorders of the Bladder, Bowel, and Pelvic Floor, March 2-5, 2005, at the Sheraton San Diego Hotel and Marina in San Diego, Calif.
The symposium will include a variety of workshops on bladder and bowel disorders, basic and advanced sessions on urodynamics studies, and updates on pelvic floor rehabilitation. For more information, visit the SUNA Web site at www.suna.org, or call 888-827-7862.
Articles in this issue
over 21 years ago
Issues in the Treatment of Patients with Hypothyroidismover 21 years ago
Health Organizations Favor Electronic Health Recordsover 21 years ago
Therapeutic Management of Bronchitisover 21 years ago
Program Advocates for Timely Prescription Refillsover 21 years ago
Cardinal Backs RFID Technologyover 21 years ago
Agreement Improves Point of Careover 21 years ago
Decision Unpopular with Health Care Professionalsover 21 years ago
The Importance of the Order of Drug Administrationover 21 years ago
Beware of Erroneous Daily Oral Methotrexate Dosing!Advertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
3
Adult Respiratory Vaccination Delivers Up to $12 in Societal Value for Every $1 Spent, Analysis Finds
4
Biologic Stewardship: The Next Frontier for Health System Pharmacists
5